logo-loader
viewNamaste Technologies Inc

Form 8.3 - Allergan plc

Form 8.3 - Allergan plc

                FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)State Street Global Advisors & Affiliates
Company dealt inAllergan plc
Class of relevant security to which
the dealings being disclosed relate
(Note 2)
US$0.0001 ordinary shares
Date of dealing17th  September 2019
  

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 LongShort
 Number(%)Number(%)
(1) Relevant securities14,997,8624.57498%  
(2) Derivatives (other than options)N/A   
(3) Options and agreements to
purchase/sell
N/A   
Total14,997,8624.57498%  

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 Number(%)Number(%)
(1) Relevant securitiesN/A   
(2) Derivatives (other than options)N/A   
(3) Options and agreements to purchase/sellN/A   
TotalN/A   

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit (Note 5)
Purchase100165.96
Purchase800166.10
Purchase4,130166.10
Purchase9,589166.10
Purchase3,620166.10
Purchase72166.10
Purchase77166.10
Sale370166.10
Sale116166.10

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
N/A   

                                                                                                                                                     
(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling,
purchasing
 varying etc.
Number of
securities to which
the option relates
(Note 7)
Exercise
price
Type, e.g.
American,
European etc.
Expiry
date
Option money
paid/received
per unit
(Note 5)
N/A      

(ii) Exercising

Product name,
e.g. call option
Number of securitiesExercise price per
unit
(Note 5)
N/A  

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)
DetailsPrice per unit
(if applicable)
(Note 5)
N/A  

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A


Is a Supplemental Form 8 attached? (Note 9)NO


Date of disclosure18th September 2019
Contact nameChetan Shah
Telephone number  +44 20 33956564
If a connected EFM, name of offeree/offeror with which connectedN/A
If a connected EFM, state nature of connection (Note 10)N/A

Quick facts: Namaste Technologies Inc

Price: 0.4

Market: TSX-V
Market Cap: $128.7 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Namaste Technologies receives purchase order for product...

Namaste Technologies (CVE: N - OTC: NXTTF) CEO Meni Morim joined Steve Darling from Proactive Vancouver in Toronto with news the company has received a purchase order for pre-rolled cannabis products from the BC Liquor Distribution Branch. Those will be available to purchase at licensed...

4 weeks, 1 day ago

RNS

Form 8.3 - Allergan plc

17 hours, 38 minutes ago

Form 8.3 - AbbVie Inc

17 hours, 42 minutes ago

Form 8.3 - Allergan plc

3 days, 17 hours ago

Form 8.3 - AbbVie Inc

3 days, 17 hours ago

Form 8.3 - Allergan plc

4 days, 18 hours ago

Form 8.3 - AbbVie Inc

4 days, 18 hours ago

Form 8.3 - Allergan plc

5 days, 17 hours ago